On December 7, 2024, the 2024 Pudong International Talent Port Forum with the theme of "Leading · Wisdom · win-win" was held in Zhangjiang Science Hall, and the forum announced and issued the list of leading talents, elite talents and engineers of Pudong New Area 2024 "Pearl Plan" and the certificate of honor. Dr. Liu Haiyang, CEO of Blitzer Biology, attended as an invited guest and was selected and awarded the title of "Pearl Leading Talent" in Pudong New Area in 2024!
BRC Biotechnology is dedicated to delivering professional, efficient, and comprehensive biosafety testing services. To further strengthen biopharmaceutical quality and safety control, we've independently established a TEM platform.
Currently, all 12 CAR-T cell therapies approved in global and Chinese markets are based on the ex vivo CAR-T approach. This type of therapy involves isolating autologous T cells from the patient's body, genetically engineering and expanding them in vitro, and then reinfusing them back into the patient to exert anti-tumor effects.
Although no replication-competent lentiviruses (RCL) have been documented to date in clinical-grade preparations, the theoretical risk persists due to potential homologous or non-homologous recombination events during vector production.
BRC Cell Biology Platform focuses on providing customers with comprehensive services, including the construction of cell sample banks, cell identification an...
Our Rapid Testing solutions are designed to streamline biopharmaceutical development and manufacturing by providing fast, accurate, and regulatory-compliant ...